13-valent pneumococcal conjugate vaccine no longer routinely recommended for adults 65 and older
The 13-valent pneumococcal conjugate vaccine (PCV13) is no longer recommended for routine use among adults aged ≥65 years, according to research published in the Nov. 22 issue of the U.S. Centers for Disease Control and ...
Nov 22, 2019
0
12